Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Carbylan Therapeutics Inc buy BiotechBee

Carbylan Therapeutics Inc
Start price
€8.10
27.06.23 / 60%
Target price
€12.00
31.07.26
Performance (%)
74.07%
End price
€14.10
04.02.24
Summary
This prediction ended on 04.02.24 with a price of €14.10. With a performance of 74.07% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Carbylan Therapeutics Inc -5.172% -5.172% 8.911%
iShares Core DAX® -3.429% 3.133% 15.455%
iShares Nasdaq 100 -6.121% -1.433% 16.794%
iShares Nikkei 225® -7.364% 1.018% 8.293%
iShares S&P 500 -4.366% 0.247% 18.541%

According to BiotechBee what are the pros and cons of Carbylan Therapeutics Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Carbylan Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 74.07%
Target price 12.000
Change
Ends at 31.07.26

Buy mit Kursziel 12,0

BiotechBee 
0
Report Share
27.06.23
In the thread Trading Carbylan Therapeutics Inc
Prediction Buy
Perf. (%) 74.07%
Target price 12.000
Change
Ends at 31.07.26

Buy beendet

BiotechBee 
0
Report Share
04.02.24

Stopped prediction by BiotechBee for Carbylan Therapeutics Inc

buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€14.10
04.02.24
€22.00
31.03.26
-20.57%
08.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€6.60
03.01.23
€10.00
31.12.25
30.22%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
03.01.23 60%